This Swedish firm’s microneedles could transform preventive healthcare – and open a billion-dollar global market
22 maj 2026
15:20
Just beneath the skin lies a treasure trove of health data. The problem is that no one has found a reliable way to extract it. Until now.
At Ascilion in Kista, a quiet but significant breakthrough in global preventive care may be taking shape.
"With our technology, you can access 5,000 biomarkers without a blood test," says CEO Simon Grant.
At Ascilion in Kista, a quiet but significant breakthrough in global preventive care may be taking shape.
"With our technology, you can access 5,000 biomarkers without a blood test," says CEO Simon Grant.
This is a paid partnership with Kista Limitless. Want to know more about Kista as an innovation hub? Visit kista.io!
The device looks something like an insulin pen crossed with a games console – think early Nintendo. A stamp-like pad studded with hundreds of tiny needles is pressed against the forearm – it feels a bit like Velcro to the touch. The demonstration isn't the finished product, but it illustrates just h...